ClinicalTrials.Veeva

Menu

Formula With Modified Content of Protein and Improved Fatty Acids and Their Impact on Infant Growth and Health (BEMIM)

L

Ludwig Maximilian University of Munich

Status

Completed

Conditions

Infant Nutrition

Treatments

Other: modified infant formula
Other: breast milk
Other: standard infant formula

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

In this study, the suitability of an infant formula with a modified content of protein and fatty acid pattern (LC-PUFA) for healthy term infants will be investigated.

Primary hypothesis to be tested is: an infant formula with a modified protein content is non inferior compared to a standard infant formula in respect to the growth of healthy term infants.

Enrollment

505 patients

Sex

All

Ages

3 to 28 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy term newborn
  • gestational age between 37 and 41 weeks
  • birth weight between the 3th and 97th weight-for-age percentile according to the EURO-Growth charts
  • fully bottle-fed (at the latest with 28 days of age) or fully breast fed
  • written parental informed consent
  • Serbian nationality

Exclusion criteria

  • malformations, congenital heart defect, congenital vascular disease, severe diseases of gastrointestinal tract, kidney, liver, central nervous system and/or metabolic disease
  • intensive care during first 14 days of life
  • participation in any other clinical study intervention
  • twins, multiple birth
  • neonatal infection
  • medication and parenteral nutrition
  • metabolic disorders
  • birth-related complications
  • severe disturbances of neonatal adaption

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

505 participants in 3 patient groups

standard infant formula
Active Comparator group
Description:
infants are fed a commercial formula during the first 4 month of life, according to protocol
Treatment:
Other: standard infant formula
modified infant formula
Experimental group
Description:
infants are fed a modified infant formula (modified protein content and fatty acid pattern) during the first 4 month of life, according to protocol
Treatment:
Other: modified infant formula
breast milk
Other group
Description:
infants are breast fed
Treatment:
Other: breast milk

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems